Exclusive NA Distributor StimDesigns holds exclusive North America distribution rights for Galileo side alternating mechano stimulation devices, enabling a simplified procurement narrative for potential buyers. Target audiences include rehabilitation clinics, pediatric and neuro clinics, stroke and spinal cord injury programs, senior care facilities, and athletic performance centers. Leverage this exclusivity to secure multi site deals and long term service contracts, supported by Galileo's 25 year industry presence and substantial clinical literature.

Proven Clinical Value Leverage Galileo's extensive clinical footprint, with 400 plus peer reviewed studies including 47 focused on children, to build trust with hospital networks, physical therapy practices, schools, and sports medicine programs. Develop clinical case studies, ROI focused proposals, and clinician education materials to differentiate from competitors. Frame the solution as a fast, efficient, whole body training modality that accelerates rehab and enhances performance.

Market Expansion Beyond medical rehab, Galileo serves general fitness and athletic performance, creating cross sell opportunities into wellness centers and performance facilities. Prioritize partnerships with clinics, universities, athletic programs, and DME distributors to scale adoption. Use a channel approach combining direct outreach, showroom demonstrations, and event marketing to demonstrate rapid training outcomes.

Channel Strategy With a lean team, prioritize channel partnerships, regional sales reps, and reseller programs to extend reach. Consider distribution partnerships with DME providers and healthcare suppliers, and integrate with existing medical procurement processes. Align marketing assets around evidence based results and patient outcomes to speed discussions with procurement teams.

Growth Readiness Current revenue range shows a small but scalable operation with significant upside from new contracts and multi site deployments. Propose flexible financing, leasing, and bundled service plans to lower adoption barriers for clinics and schools. Emphasize exclusive NA rights and Galileo's proven track record to justify investment and shorten sales cycles.